Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors: Introduction of a multiinstitutional research project

Strahlentherapie und Onkologie

Volumn 180, Issue 10, 2004, Pages 609-615

  Zips, Daniel ^a   Adam, Markus ^b   Flentje, Michael ^c   Haase, Axel ^c   Molls, Michael ^b   Mueller Klieser, Wolfgang ^d   Petersen, Cordula ^a   Philbrook, Christine ^b   Schmitt, Peter ^c   Thews, Oliver ^d   Walenta, Stefan ^d   Baumann, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Fractionated radiotherapy; Hypoxia; Microenvironment; Tumor xenografts

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CARBONATE DEHYDRATASE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; LACTATE DEHYDROGENASE; PIMONIDAZOLE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULOTROPIN;

ANIMAL MODEL; BIOLUMINESCENCE; BIOPSY; CANCER CELL; CANCER GRAFT; CANCER RADIOTHERAPY; GLUCOSE METABOLISM; HEAD AND NECK TUMOR; HUMAN; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE MOUSE; PLASMINOGEN ACTIVATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMALS; CELL HYPOXIA; HUMANS; MICE; MOLECULAR BIOLOGY; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN CONSUMPTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 5444259172     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1285-3     Document Type: Review

References (70)

1. Andreasen PA, Kjoller L, Christensen L, et al. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
2. Baker EA, Bergin FG, Leaper DJ. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. Mol Pathol 2000;53:307-12.
3. Baumann M, Appold S, Zimmer J, et al. Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy. Acta Oncol 2001;40:519-28.
4. Becker A, Stadler P, Krause U, et al. [Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas.] Strahlenther Onkol 2001;177:182-8.
5. Berney CR, Yang JL, Fisher RJ, et al. Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res 1998;18:973-7.
6. Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:349-53.
7. Bussink J, Kaanders JH, Rijken PF, et al. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer 1998;77:57-64.
8. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003;67:3-15.
9. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
10. Dunst J, Ahrens S, Paulussen M, et al. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors. Strahlenther Onkol 2001;177:153-9.
11. Dunst J, Stadler P, Becker A, et al. Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol 2003;179:521-6.
12. Gil S, Zaderenzo P, Cruz F, et al. Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. Bioorg Med Chem 1994;2:305-14.
13. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
14. Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998;91:3300-7.
15. Graham CH, Forsdike J, Fitzgerald CJ, et al. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999;80:617-23.
16. Gray LH, Conger AD, Ebert MEA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-48.
17. Henke M, Sindlinger F, Ikenberg H, et al. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004;180:45-51.
18. Höckel M, Schlenger K, Mitze M, et al. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996;6:3-9.
19. Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001;28:36-41.
20. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
21. Horsman M. Hypoxia in tumors: its relevance, identification, and modification. In: Beck-Bornholdt HP, ed. Current topics in clinical radiobiology of tumors. Berlin: Springer, 1993:99-112.
22. Horsman M. The use of oxygen electrodes to predict radiobiological hypoxia in tumors. In: Vaupel P, Kelleher DK, Günderoth M, eds. Tumor oxygenation. Stuttgart: Fischer, 1995:49-57.
23. Horsman M, Overgaard J. The oxygen effect. In: Steel GG, ed. Basic clinical radiobiology, 2nd edn. London: Arnold, 2001:132-40.
24. Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 2002;62:7066-74.
25. Kallman RF, ed. Rodent tumor models in experimental cancer therapy. New York: Pergamon Press, 1987.
26. 2 histograph, [3H]misonidazole binding and paired survival assay. Radiat Res 1996;145:491-500.
27. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-4.
28. Koch CJ, Evans SM. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. Adv Exp Med Biol 2003;510:285-92.
29. Michiels C, Arnould T, Remade J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000;1497:1-10.
30. Molls M, Vaupel P, eds. Blood perfusion and microenvironment of human tumors. Berlin: Springer, 1998.
31. Mueller-Klieser W, Schaefer C, Walenta S, et al. Assessment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res 1990;50:1681-5.
32. Mueller-Klieser W, Walenta S. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 1993;25:407-20.
33. Mueller-Klieser W, Walenta S, Paschen W, et al. Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting. J Natl Cancer Inst 1988;80:842-8.
34. Nakata S, Ito K, Fujimori M, et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int J Cancer 1998;79:179-86.
35. Odrazka K, Petera J, Kohlova T, et al. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma. Strahlenther Onkol 2003;179:615-9.
36. Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002;38:2116-27.
37. Raleigh JA, Chou SC, Arteel GE, et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 1999;151:580-9.
38. Raleigh JA, Dewhirst MW, Thrall DE. Measuring tumor hypoxia. Semin Radiat Oncol 1996;6:37-45.
39. Rijken PF, Bernsen HJ, van der Kogel AJ. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 1995;50:141-53.
40. Robinson SP, Rodrigues LM, Ojugo AS, et al. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 1997;75:1000-6.
41. Rockwell S, Knisely JPS. Hypoxia and angiogenesis in experimental tumors: therapeutic implications. In: Goldberg ID, Rosen EM, eds. Regulation of angiogenesis. Basel: Birkhäuser, 1997:335-60.
42. Rockwell S, Moulder JE. Hypoxic fractions of human tumors xenografted into mice: a review. Int J Radiat Oncol Biol Phys 1990;19:197-202.
43. Rockwell S, Moulder JE, Martin DF. Tumor-to-tumor variability in the hypoxic fractions of experimental rodent tumors. Radiother Oncol 1984;2:57-64.
44. Rofstad EK, Maseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol 1999;75:1377-93.
45. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001;177:462-8.
46. Salven P, Heikkila P, Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997;76:930-4.
47. Sandstrom M, Johansson M, Sandstrom J, et al. Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression. Int J Dev Neurosci 1999;17:473-81.
48. Schafer U, Micke O, Muller SB, et al. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol 2003;179:527-34.
49. Schreiber A, Krause M, Zips D, et al. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. Strahlenther Onkol 2004;180:375-82.
50. Schwickert G, Walenta S, Sundfor K, et al. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55:4757-9.
51. Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71-103.
52. Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 1997;94:6658-63.
53. Silva AC, Lee SP, Yang G, et al. Simultaneous blood oxygenation level-dependent and cerebral blood flow functional magnetic resonance imaging during forepaw stimulation in the rat. J Cereb Blood Flow Metab 1999;19:871-9.
54. Stadler P, Becker A, Feldmann HJ, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749-54.
55. Stadler P, Feldmann HJ, Creighton C, et al. Clinical evidence for correlation of insufficient tissue oxygen supply (hypoxia) and tumor-associated proteolysis in squamous cell carcinoma of the head and neck. Int J Biol Markers 2000;15:235-6.
56. Stüben G, Stuschke M, Knuhmann K, et al. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies. Radiother Oncol 1998;48:143-8.
57. Suit H, Maeda M. Oxygen effect factor and tumor volume in the C3H mouse mammary carcinoma. A preliminary report. Am J Roentgenol Radium Ther Nucl Med 1966;96:177-82.
58. Suit HD, Zietman A, Tomkinson K, et al. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report. Int J Radiat Oncol Biol Phys 1990;18:365-73.
59. 1H STEAM/31P ISIS spectroscopy in vivo. Magn Reson Med 1996;35:465-70.
60. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28:29-35.
61. Vaupel P, Thews O, Höckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001;18:243-59.
62. Vordermark D, Brown JM. Endogenous markers of tumor hypoxia: predictors of clinical radiation resistance? Strahlenther Onkol 2003;179:801-11.
63. Walenta S, Chau TV, Schroeder T, et al. Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 2003;129:321-6.
64. Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 1997;150:409-15.
65. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60:916-21.
66. Wenger RH. Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 2000;203:1253-63.
67. Withers HR, McBride WH. Biological basis of radiation therapy. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 3rd edn. Philadelphia: Lippincott-Raven, 2000:99-106.
68. Wouters BG, Koritzinsky M, Chiu RK, et al. Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol 2003;13:31-41.
69. Wright EA, Howard-Flanders P. The influence of oxygen on the radiosensitivity of mammalian tissues. Acta Radiol 1957;48:26-32.
70. Zips D, Eicheler W, Bruchner K, et al. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol 2001;77:1185-93.